Development and validation of a risk score to predict mortality during TB treatment in patients with TB-diabetes comorbidity

摘要

BackgroundMaking an accurate prognosis for mortality during tuberculosis (TB) treatment in TB-diabetes (TB-DM) comorbid patients remains a challenge for health professionals, especially in low TB prevalent populations, due to the lack of a standardized prognostic model.